Korosteleva T A, Chistiakova Z M
Vopr Onkol. 1979;25(8):77-81.
In tissues of non-lineal rats receiving dimethyl amino-azobenzene (DAAB) or its non-carcinogenic analog diethyl amino-azobenzene (DEAB) there was found, using rabbit serum against an artificial complex RNA + MBSA (methylated bovine serum albumin), the RNA-haptene in the reaction of counter-immunoelectrophoresis in the liver and serum of rats in definite terms since the start of DAAB administration. RSR reaction and immunoelectrophoresis have demonstrated the presence of circulating antibodies against hepatic cell RNA. The kinetic of antibodies against RNA is characterized by their increase after 15 DAAB injections, their decrease to the 60th day and again an increase by the time of the tumor appearance. It is suggested that the phenomena of sensibilization and desensitization to the antigens arising in the process of carcinogenesis play a definite role in "cancelling" the antitumor immunity.
在接受二甲基氨基偶氮苯(DAAB)或其非致癌类似物二乙氨基偶氮苯(DEAB)的非线性大鼠组织中,自开始给予DAAB起,使用针对人工复合物RNA + MBSA(甲基化牛血清白蛋白)的兔血清,在大鼠肝脏和血清的对流免疫电泳反应中明确检测到RNA - 半抗原。RSR反应和免疫电泳已证明存在针对肝细胞RNA的循环抗体。抗RNA抗体的动力学特征是在注射15次DAAB后其增加,到第60天下降,并且在肿瘤出现时再次增加。有人认为,在致癌过程中产生的对抗原的致敏和脱敏现象在“消除”抗肿瘤免疫中起一定作用。